pillbase.ru

Praxbind

Active substance: Idarucizumab

INJECTION · IDARUCIZUMAB 50 mg/mL

United StatesActive

Marketing holder: Boehringer Ingelheim Pharmaceuticals, Inc.

Verified 2026-10-09 · openFDA NDC

Analogues in other countries
Composition
Analogues by country

Products with the same active substance registered in other countries.

CountryProducts
RU 2
  • Праксбайнд®
    раствор для внутривенного введения, 50 мг/мл, 50 мл (original in Russian, GRLS)
    ЛП-№(001910)-(РГ-RU)
    Берингер Ингельхайм Интернешнл ГмбХ
  • Праксбайнд®
    раствор для внутривенного введения, 50 мг/мл, 50 мл (original in Russian, GRLS)
    ЛП-005017
    Берингер Ингельхайм Интернешнл ГмбХ
EU 1
  • Praxbind
    idarucizumab
    EMEA/H/C/003986
    Boehringer Ingelheim International GmbH
Import and control

Control by country

  • Russiaprescription only

    Source: GRLS (Russian state register) · record 01a120c3-43d8-77ee-b5e3-4f39c62ce517,01a120c5-c8f8-750e-b0ac-4fdc71e039cb;count=2 · valid from 2026-10-09 · verified 2026-10-09

  • United Statesprescription only

    Source: openFDA NDC · record 01a1209a-0585-773f-bfaa-4d6e8eb6c2f1;count=1 · valid from 2026-10-09 · verified 2026-10-09

More on control status
Registration
Registration number
0597-0197
Registration status
Active
Dispensing
Prescription only
Route
INTRAVENOUS
Sources
  • product · openFDA NDC · 0597-0197 · Verified 2026-10-09 · open in source
  • registration_status · openFDA NDC · 0597-0197 · Verified 2026-10-09 · open in source
  • ingredients.0 · openFDA NDC · 0597-0197 · Verified 2026-10-09 · open in source